Romanò Massimo, Oldani Sabina, Reina Valter, Sofia Michele, Castiglioni Claudia
Organizing Committee-Postgraduate Master in Palliative Care, University of Milan, 20122 Milan, Italy.
Palliative Care ASST Milano Ovest, 20020 Milan, Italy.
Healthcare (Basel). 2022 Jun 2;10(6):1031. doi: 10.3390/healthcare10061031.
Patients with irreversible malignant and non-malignant diseases have comparable mortality rates, symptom burdens, and quality of life issues; however, non-cancer patients seldom receive palliative care (PC) or receive it late in their disease trajectory. To explore the characteristics of non-cancer patients receiving PC in northern Italy, as well as the features and outcomes of their care, we retrospectively analyzed the charts of all non-cancer patients initiating PC regimens during 2019 in three publicly funded PC departments in Italy’s populous Lombardy region. We recorded the baseline variables (including data collected with the NECPAL CCOMS-ICO-derived questionnaire used since 2018 to evaluate all admissions to the region’s PC network), as well as treatment features (setting and duration) and outcomes (including time and setting of death). Of the 2043 patients admitted in 2019, only 12% (243 patients—131 females; mean age 83.5 years) had non-oncological primary diagnoses (mainly dementia [n = 78], heart disease [n = 55], and lung disease [n = 30]). All 243 had Karnofsky performance statuses ≤ 40% (10−20% in 64%); most (82%) were malnourished, 92% had ≥2 comorbidities, and 61% reported 2−3 severe symptoms (pain, dyspnea, and fatigue). Fifteen withdrew or were discharged from the study PCN; the other 228 remained in the PCN and died in hospice (n = 133), at home (n = 9), or after family-requested transfer to an emergency department (n = 1). Most deaths (172/228, 75%) occurred <3 weeks after PC initiation. These findings indicate that the PCN network we studied cares for few patients with life-limiting non-malignant diseases. Those admitted have advanced-stage illness, heavy symptom burdens, low performance statuses, and poor survival. Additional efforts are needed to improve PCN accessibility for non-cancer patients.
患有不可逆恶性和非恶性疾病的患者在死亡率、症状负担和生活质量问题方面相当;然而,非癌症患者很少接受姑息治疗(PC),或者在疾病进程后期才接受。为了探究意大利北部接受PC的非癌症患者的特征,以及他们的护理特点和结果,我们回顾性分析了2019年在意大利人口众多的伦巴第地区三个公共资助的PC科室开始接受PC治疗方案的所有非癌症患者的病历。我们记录了基线变量(包括自2018年以来用于评估该地区PC网络所有入院患者的由NECPAL CCOMS - ICO衍生问卷收集的数据),以及治疗特点(环境和持续时间)和结果(包括死亡时间和地点)。在2019年入院的2043名患者中,只有12%(243名患者——131名女性;平均年龄83.5岁)有非肿瘤学的原发性诊断(主要是痴呆症[n = 78]、心脏病[n = 55]和肺病[n = 30])。所有243名患者的卡氏功能状态均≤40%(64%为10 - 20%);大多数(82%)营养不良,92%有≥2种合并症,61%报告有2 - 3种严重症状(疼痛、呼吸困难和疲劳)。15名患者退出或从研究PCN出院;其他228名患者仍留在PCN,并在临终关怀机构死亡(n = 133)、在家中死亡(n = 9)或在家属要求转至急诊科后死亡(n = 1)。大多数死亡(172/228,75%)发生在开始PC治疗后<3周。这些发现表明,我们研究的PCN网络照顾的生命有限的非恶性疾病患者很少。入院患者病情处于晚期,症状负担重,功能状态低,生存率低。需要做出更多努力来提高非癌症患者对PCN的可及性。